Figure 4
From: Screening for oncogenic AF1q expression predicts disease recurrence in gastric cancer patients
Kaplan–Meier analysis for disease-specific survival in nodal-positive gastric cancer (GC) patients. Patients with moderate (1) and high (2) CD44 expression die earlier compared to patients with CD44-negative (0) GC (log rank: p = 0.031).
